DERM On Watchlist, FDA Panel Nod For GILD, So Long, CVRS And AVDR

Today's Daily Dose brings you news about the acquisition of Corindus and Avedro; FDA panel recommending approval of Gilead's Descovy; and stellar results of Hanger and Dermira.

from RTT - Biotech https://ift.tt/2YMBB3m
via IFTTT